You have 9 free searches left this month | for more free features.

GVD

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Classical Hodgkin Lymphoma, Refractory or Relapsed Classical Hodgkin Lymphoma Trial in Guangzhou (PD-1 inhibitor, PD-1

Recruiting
  • Classical Hodgkin Lymphoma
  • Refractory or Relapsed Classical Hodgkin Lymphoma
  • PD-1 inhibitor
  • PD-1 inhibitor, gemcitabine, vinorelbine and doxorubicin liposome
  • Guangzhou, Guangdong, China
  • +2 more
May 6, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Guangzhou (gemcitabine, vinorelbine and doxorubicin liposome, with or without

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • gemcitabine, vinorelbine and doxorubicin liposome, with or without rituximab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Aug 3, 2019

Systemic Microvascular Reactivity in Heart Transplant Patients

Recruiting
  • Heart Transplantation
  • skin microvascular reactivity
  • Rio de Janeiro, Brazil
    Eduardo Tibiriçá
Feb 14, 2023

Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)

Not yet recruiting
  • Pediatric Patients
  • +2 more
  • CliniMACS Plus Instrument
  • Aurora, Colorado
    Children's Hospital Colorado
Jun 29, 2022

Classical Hodgkin Lymphoma Trial in China (Tislelizumab, Salvage Chemotherapy)

Recruiting
  • Classical Hodgkin Lymphoma
  • Beijing, Beijing, China
  • +6 more
Jan 4, 2022

Hodgkin Disease Lymphoma Trial in China (Penpulimab, Investigator's choice of Chemotherapy)

Recruiting
  • Hodgkin Disease Lymphoma
  • Guangzhou, Guangdong, China
  • +5 more
Feb 15, 2022

Primary Mediastinal Large B-cell Lymphoma Trial in Beijing (Decitabine, GVD chemo, SHR-1210)

Unknown status
  • Primary Mediastinal Large B-cell Lymphoma
  • Beijing, Beijing, China
  • +1 more
Nov 29, 2018

Hypertension Trial in Florianopolis (Application Group (GA))

Not yet recruiting
  • Hypertension
  • Application Group (GA)
  • Florianopolis, Santa Catarina, Brazil
    Universidade Federal de Santa Catarina
Oct 7, 2022

B-CD30 + Hodgkin Lymphoma International Multi-center

Completed
  • Classical Hodgkin Lymphoma
  • Relapsed or Refractory Classical Hodgkin Lymphoma
    • Busan, Korea, Republic of
      Pusan National University Hospital
    Jun 3, 2021

    Profiling Vulvodynia Based on Neurobiological and Behavioral

    Completed
    • Vulvodynia
      • Los Angeles, California
        University of California, Los Angeles (UCLA)
      Oct 16, 2019

      Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)

      Terminated
      • Peripheral T-Cell Lymphoma
      • Saint Louis, Missouri
        Washington University
      Apr 14, 2020

      Lymphoma, Non-Hodgkin;Hodgkin Disease Trial in Jinan (R-CHOP/CHOPE or ABVD chemo regimen, R-CDOP/CDOPE or DBVD chemo regimen)

      Unknown status
      • Lymphoma, Non-Hodgkin;Hodgkin Disease
      • R-CHOP/CHOPE or ABVD chemotherapy regimen
      • R-CDOP/CDOPE or DBVD chemotherapy regimen
      • Jinan, Shandong, China
        Department of Hematology, Provincial Hospital Affiliated to Shan
      Apr 1, 2019

      Pathophysiology of Gastrointestinal Graft-versus-Host Disease

      Withdrawn
      • Graft-Versus-Host-Disease
        • (no location specified)
        Oct 5, 2017

        Rett Syndrome Trial in France (Blood sampling)

        Completed
        • Rett Syndrome
        • Blood sampling
        • Besançon, France
        • +8 more
        Aug 26, 2016

        Lymphoma Trial in Puerto Rico, United States (gemcitabine HCl, pegylated liposomal doxorubicin HCl, vinorelbine tartrate)

        Completed
        • Lymphoma
        • gemcitabine hydrochloride
        • +2 more
        • Anniston, Alabama
        • +75 more
        Jul 12, 2016

        Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

        Completed
        • Adult Lymphocyte Depletion Hodgkin Lymphoma
        • +4 more
        • monoclonal antibody SGN-30
        • +6 more
        • Chicago, Illinois
          Cancer and Leukemia Group B
        Feb 10, 2015

        AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

        Completed
        • AML
        • +8 more
        • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        Jul 14, 2016

        Multiple Myeloma, Leukemia, Lymphoma Trial in Houston (drug, procedure, other)

        Completed
        • Multiple Myeloma
        • +2 more
        • Houston, Texas
          UT MD Anderson Cancer Center
        May 23, 2012